Closed · HR00117S0019 · CFDA 12.910 · Discretionary
Pandemic Prevention Platform (P3)
Federal grant opportunity posted by DARPA - Biological Technologies Office, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- May 8, 2017
- Close date
- -
- Expected awards
The verdict
Pandemic Prevention Platform (P3) is a closed discretionary listing from DARPA - Biological Technologies Office that offered Varies by applicant. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 73 other opportunities from DARPA - Biological Technologies Office.
- Varies
- award range
- Closed
- application status
- 12.910
- CFDA program
- 73
- other opportunities from DARPA - Biological Technologies Office
Archived opportunity record
Pandemic Prevention Platform (P3) is closed (last close May 8, 2017). Check the agency catalog for replacement NOFOs. DARPA - Biological Technologies Office still indexes 73 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed May 8, 2017
Instrument
Procurement Contract
Description
DARPA is soliciting innovative research proposals to develop an end-to-end platform capability for preventing a pandemic threat in <60 days. Recent advances in medical countermeasures have formed a strong foundation, enabling the creation of a true end-to-end pandemic prevention platform. However, experience gained from conventional responses to emerging infectious diseases (MERS, SARS, dengue, chikungunya, Ebola) has demonstrated that significant bottlenecks hinder the rapid response to an emerging infectious threat . Current challenges include the ability to rapidly produce virus needed to test and evaluate therapies, to obtain high potency antibodies within the first weeks of an outbreak, or to scale delivery methods into humans to produce protective levels inside the patient.
Catch-all / unrestricted eligibility mark · HR00117S0019
Grants.gov marks Pandemic Prevention Platform (P3) with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Procurement Contract. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the DARPA - Biological Technologies Office book (27 peers, 36% of 74).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
P3 BAA Coordinator
More from DARPA - Biological Technologies Office
What to do next
Pandemic Prevention Platform (P3) is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.910 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |